iMedix Medical Content Engine 3.13.37

Hello,

Sign up to join our community!

Welcome Back,

Please sign in to your account!

Forgot Password,

Lost your password? Please enter your email address. You will receive a link and will create a new password via email.

Sorry, you do not have permission to ask a question, You must login to ask a question.

Modalert: Uses, dosage, side effects, warnings & patient reviews

Modalert

Modalert

Modalert

Modafinil
Modalert is a generic medication containing the active ingredient modafinil. It is a wakefulness-promoting agent used to treat excessive daytime sleepiness associated with specific medical conditions such as narcolepsy, obstructive sleep apnea, and shift work sleep disorder.
  • ActiveIngredient: Modafinil
  • DosageForm: Oral tablets
  • Dosage: Tablets: 100 mg, 200 mg.
  • Indications: Improvement of wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD) (No FDA-approved therapeutic uses for this specific brand in the U.S.).
  • Manufacturer: Sun Pharmaceutical Industries Ltd.
  • Storage: Store at room temperature 20°C–25°C (68°F–77°F); protect from moisture and light.
  • Drug Status: Not Approved

What is Modalert (Modafinil)?

Modalert is a brand name for the generic drug modafinil, a medication classified as a wakefulness-promoting agent. Its exact mechanism of action is not fully understood, but it is distinct from traditional stimulants like amphetamines. It is believed to work by affecting certain neurotransmitters in the brain that regulate the sleep-wake cycle, promoting alertness without causing generalized stimulation of the central nervous system.

The active ingredient in Modalert is the same as in the brand-name drug Provigil. Depending on the country and manufacturer, products marketed as modafinil may be available as brand-name or generic options. It is prescribed to help improve wakefulness in patients with diagnosed sleep disorders.

Important: Modalert is a Schedule IV controlled substance in many countries, including the United States, due to its potential for abuse or dependence. It should only be used under medical supervision after an appropriate diagnosis is confirmed.

How to Take Modalert

Adherence to prescribed dosing is important for safety and effectiveness. Do not adjust your dose without consulting your doctor.

Administration and Timing

A common adult dose of modafinil is 200 mg taken orally once daily, but the exact dose and schedule depend on the condition being treated and individual factors. For conditions like narcolepsy or obstructive sleep apnea, it is typically taken in the morning to promote daytime wakefulness. For shift work sleep disorder, it is taken approximately 1 hour before the start of the work shift.

Modalert can be taken with or without food; however, taking it with food may slightly delay its absorption and the onset of action. Take the tablet with water, following your prescriber’s instructions.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is close to the time of your next dose, or if it is already the afternoon or evening, skip the missed dose. Do not double your dose to make up for a missed one, as this increases the risk of insomnia or other side effects.

Important Precautions

  • Modalert is not a replacement for healthy sleep habits. Individuals with sleep apnea should continue any prescribed therapy (such as CPAP).
  • Do not drive or operate hazardous machinery until you know how Modalert affects you, as responses can vary.

Side Effects of Modalert

Like all medications, Modalert (modafinil) can cause adverse reactions. The following table categorizes these effects based on frequency and severity.

Common and Serious Side Effects of Modalert (Modafinil)
FrequencySide EffectsAction to Take
Common
  • Headache (For more information, see headache.)
  • Nausea, nervousness, or dizziness
  • Insomnia (if taken too late in the day)
  • Dry mouth or upset stomach
  • Back pain or nasal congestion
These are often mild and may decrease over time. Inform your doctor if they are persistent or bothersome.
Serious (Seek Medical Help)
  • Skin rash, blistering, or peeling, especially with fever or mouth sores (see Warnings).
  • Chest pain, palpitations, or irregular heartbeat.
  • Signs of depression, anxiety, aggression, hallucinations, or suicidal thoughts.
  • Signs of an allergic reaction: hives, difficulty breathing, swelling of face/lips/tongue.
  • Symptoms of a severe multiorgan hypersensitivity reaction (fever, rash, organ inflammation).
Stop taking Modalert and seek urgent medical advice or emergency care if severe rash, allergic symptoms, chest pain, or serious mental/mood changes occur.

What is Modalert Used For?

Modalert (modafinil) is indicated for the treatment of excessive daytime sleepiness associated with the following specific, diagnosed medical conditions:

FDA-Approved Medical Uses

  • Narcolepsy: A chronic neurological disorder characterized by overwhelming daytime drowsiness and sudden attacks of sleep.
  • Obstructive Sleep Apnea (OSA): Used as adjunctive therapy to continuous positive airway pressure (CPAP) to treat residual sleepiness in patients where CPAP alone is insufficient. It does not treat the underlying airway obstruction.
  • Shift Work Sleep Disorder (SWSD): For individuals who experience insomnia when trying to sleep and excessive sleepiness when they need to be awake during night shift work schedules.

It is important to note that Modalert is a treatment for the symptom of sleepiness, not a cure for the underlying disorders. A proper diagnosis from a sleep specialist is required before use.

Off-Label Use and Important Limitations

Some physicians may prescribe modafinil for conditions not formally approved by regulatory agencies (off-label use), such as excessive daytime sleepiness from other causes, when they judge potential benefits to outweigh risks. Any such use should only be undertaken under medical supervision with a clear understanding of potential adverse effects and interactions. For context on stimulant-like medicines, see our article on stimulant drugs and their effects.

Modalert is not approved for use in children or adolescents for any condition. It is also not indicated as a treatment for general fatigue or as a substitute for healthy sleep.

Interactions Alcohol:

Unsafe
The combination of Modalert and alcohol is not recommended. Modalert may alter the perception of alcohol-related impairment, which can increase the risk of unsafe decisions or additional alcohol intake. Individuals with a history of alcoholism or substance abuse should use particular caution.

Interactions Other Medications:

Consult your doctor
Modalert interacts with many drugs. It is a moderate inducer of the CYP3A4 liver enzyme, which can reduce the effectiveness of medications metabolized by this pathway. Crucially, it can reduce the effectiveness of hormonal contraceptives (e.g., birth control pills, patches, implants), increasing the risk of unintended pregnancy. Alternative or additional non-hormonal birth control methods may be needed. A review of all your medications with a doctor is recommended.

Special Groups Pregnancy:

Consult your doctor
There is limited data on the use of modafinil in pregnant women. It should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. Due to its interaction with hormonal birth control, planning for pregnancy may require medical guidance.

Special Groups Breastfeeding:

Consult your doctor
Limited data suggest modafinil may pass into breast milk. Decisions about breastfeeding while using modafinil should be made with a healthcare professional, considering maternal benefit and potential infant risk.

Special Groups Elderly:

Use with caution
Elderly patients may be more sensitive to the effects of modafinil. Dose selection may start at the lower end of the dosing range due to potential for decreased hepatic, renal, or cardiac function.

Special Groups Children:

Unsafe
The safety and effectiveness of modafinil in pediatric patients have not been established. It is not indicated for use in children or adolescents.

Effects on Activities Driving:

Use with caution
Although Modalert promotes wakefulness, it does not replace adequate sleep. Individuals may still experience periods of impaired alertness. Do not drive or engage in other potentially dangerous activities until you are confident in your ability to maintain alertness.

Effects on Activities Operating Machinery:

Use with caution
The same caution as for driving applies. Assess your level of wakefulness and coordination before operating machinery.

Important Safety Concerns and Considerations

Severe Dermatological Reactions

Although rare, serious and potentially fatal skin reactions, including Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) have been reported. The onset of these reactions can occur initially as a seemingly mild rash. If a rash develops, Modalert should generally be stopped and promptly evaluated by a clinician, unless the rash is clearly not drug-related. For more on this serious condition, see Stevens-Johnson Syndrome.

Psychiatric Effects

Modalert may precipitate or exacerbate psychiatric symptoms. Cases of mania, delusions, hallucinations, suicidal ideation, and aggression have been reported, primarily in patients with a pre-existing history of psychosis, depression, or mania. Close clinical monitoring is advised, especially at the start of therapy and after any dose increase.

Cardiovascular Effects

Modafinil can increase heart rate and blood pressure. Caution is advised in patients with cardiovascular disease. It is generally not recommended in patients with a history of left ventricular hypertrophy or in those with mitral valve prolapse who have experienced symptoms with stimulant use. Patients experiencing chest pain, palpitations, or shortness of breath should seek medical evaluation.

Potential for Dependence

As a Schedule IV controlled substance, modafinil has a potential for abuse and psychological dependence. Misuse can lead to tolerance, meaning higher doses are needed for the same effect, and dependence. It should be used strictly as prescribed.

Multi-Organ Hypersensitivity

DRESS, while rare, is a severe reaction that can involve fever, rash, and inflammation of internal organs (e.g., liver, kidneys). If signs appear, immediate discontinuation and medical evaluation are required.

Critical Warnings for Modalert Use

Warning: Serious Skin Rashes

Modalert can cause serious dermatologic reactions that may require hospitalization and can be life-threatening. These include SJS and TEN. If a rash appears, stopping therapy and prompt medical evaluation are important. The risk may be increased in children, though Modalert is not approved for pediatric use.

Warning: Hormonal Contraceptive Efficacy

Modalert can reduce the effectiveness of hormonal contraceptives, including products containing ethinyl estradiol. This interaction can make birth control pills, patches, implants, and vaginal rings less effective and increase the risk of unintended pregnancy. Women of childbearing potential should use an alternative, non-hormonal, or additional barrier method of contraception during Modalert therapy and for one month after discontinuation. For information on contraceptive options, see birth control methods.

Psychiatric and Cardiovascular Monitoring

Patients should be monitored for the emergence or worsening of depression, suicidal thoughts, or other psychiatric symptoms. Blood pressure and heart rate should be monitored in patients on modafinil, especially those with underlying hypertension or cardiovascular conditions.

Drug Interactions

In addition to contraceptives, Modalert can alter the blood levels of drugs metabolized by CYP3A4 (e.g., some statins, antifungals) or CYP2C19. Concurrent use with monoamine oxidase (MAO) inhibitors is generally not recommended or may require careful monitoring. Patients should provide their doctor with a complete list of all medications and supplements.

Modalert Dosage Information

The following dosing information is for educational purposes and is not an instruction to start or change therapy without medical supervision. The prescribing physician will determine the optimal dose based on the specific condition being treated and individual patient factors.

Modalert (Modafinil) Standard Dosage Guidelines
ConditionRecommended Adult DoseAdministration Notes
Narcolepsy or Obstructive Sleep Apnea (OSA)200 mg taken orally once daily.Administered as a single dose in the morning. Higher doses (up to 400 mg/day) have been used in studies; benefit beyond 200 mg may vary by patient.
Shift Work Sleep Disorder (SWSD)200 mg taken orally once daily.Administered approximately 1 hour prior to the start of the work shift.

Dosage Adjustments

  • Severe Hepatic Impairment: The dose is typically reduced in severe liver impairment.
  • Elderly Patients: Consideration may be given to using a lower dose due to the greater likelihood of decreased organ function.
  • Missed Dose: As noted in General Instructions, do not double dose.

Doses above 200 mg/day may increase adverse effects and should only be used if specifically prescribed.

Drug Interactions with Modalert

Modalert (modafinil) has clinically significant interactions with several classes of medications. The following table outlines key interactions.

Significant Drug Interactions with Modalert (Modafinil)
Interacting Substance Class/ExampleEffect of InteractionRecommendation
Hormonal Contraceptives
(e.g., pills, patches, rings containing ethinyl estradiol)
Modafinil induces metabolism, decreasing contraceptive levels and increasing risk of pregnancy.Use alternative or additional non-hormonal birth control (e.g., condoms) during and for 1 month after stopping modafinil.
CYP2C19 Substrates
(e.g., diazepam, phenytoin, some SSRIs)
Modafinil may inhibit metabolism, increasing levels of these drugs and risk of their side effects.Monitoring and potential dose adjustment of the interacting drug may be necessary.
CYP3A4 Substrates
(e.g., cyclosporine, some statins, triazolam)
Modafinil may induce metabolism, decreasing levels and effectiveness of these drugs.Monitoring and potential dose adjustment of the interacting drug may be necessary.
Monoamine Oxidase (MAO) InhibitorsPotential pharmacodynamic interaction. Theoretical risk of increased CNS stimulation or hypertension.Concomitant use is generally not recommended, or requires careful monitoring.
WarfarinModafinil may affect warfarin exposure and anticoagulant response.Close monitoring of prothrombin time/INR is recommended, especially after starting or stopping modafinil.

Important: This is not an exhaustive list. Always inform your healthcare provider of all medications, supplements, and herbal products you are taking.

FAQs

Modalert and Provigil contain the same active ingredient, modafinil. Provigil is the original brand-name drug, while Modalert is a branded generic product in some markets. Generics must demonstrate bioequivalence to the brand-name drug, meaning they deliver the same amount of active ingredient into the bloodstream at the same rate. For more on generic medications, see our article on generic medicines.
The onset of action for modafinil may occur within about 1 to 2 hours after oral administration in many people. Its wakefulness-promoting effects can last for many hours, which is why it is usually taken once daily in the morning to reduce the risk of interfering with nighttime sleep.
Modalert is not FDA-approved for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) or for weight loss. While some studies have explored modafinil for these purposes (off-label use), it is not a standard treatment. Using it for ADHD or weight loss without a doctor's supervision is not advised and carries risks. For comparison with a common ADHD medication, see information on dextroamphetamine.
Modalert (modafinil) is classified as a Schedule IV controlled substance in the U.S., indicating it has a lower potential for abuse compared to Schedule II stimulants like amphetamines. However, cases of misuse, dependence, and psychological addiction have been reported, particularly when used outside of prescribed guidelines or at higher-than-recommended doses.
Standard workplace drug screens typically test for amphetamines, cocaine, opioids, marijuana, and PCP. Modafinil is not usually part of these panels. False positives are uncommon, but if an initial screen is unexpected, confirmatory testing (such as GC/MS) can differentiate substances. If you are subject to drug testing, inform the testing laboratory that you are taking a prescribed medication.

Additional Information

Storage and Handling

Store Modalert tablets at room temperature, between 20°C to 25°C (68°F to 77°F), in a tightly closed container. Protect from excessive moisture and light. Keep all medications out of the reach of children and pets.

Regulatory Status and Sourcing

Modafinil is an FDA-approved active ingredient (as Provigil). However, Modalert is a branded product marketed in some countries and may not be FDA-approved for distribution in the United States. Medications purchased from international or online pharmacies may not meet local regulatory standards for safety and quality. There is a risk of receiving counterfeit, subpotent, superpotent, or contaminated products. Obtain prescription medications only through licensed pharmacies and with a valid prescription.

Overdose

In cases of suspected overdose, symptoms may include agitation, insomnia, anxiety, confusion, nausea, diarrhea, tachycardia, and hypertension. There is no specific antidote. Management involves supportive care and monitoring of vital signs. Contact a poison control center or seek emergency medical attention immediately.

References and Medical Sources

The information on this page is based on official prescribing information and clinical guidelines for modafinil.

  1. U.S. Food and Drug Administration (FDA). Provigil (modafinil) Prescribing Information. [Updated 2015]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020717s037s038lbl.pdf
  2. MedlinePlus. Modafinil. U.S. National Library of Medicine; [Updated 2022]. https://medlineplus.gov/druginfo/meds/a602016.html
  3. Drugs.com. Modafinil Professional Monograph. Drugs.com; [Updated 2024]. https://www.drugs.com/monograph/modafinil.html
  4. Morgenthaler, T. I., et al. “Practice Parameters for the Treatment of Narcolepsy and other Hypersomnias of Central Origin.” Sleep. 2007;30(12):1705-1711.

Disclaimer: The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.

You must login to add a comment.

Popular Questions

Top Members

Join the discussion

Comments are published after moderation. User opinions do not constitute medical advice.

We sincerely appreciate you taking the time to share your feedback. Every user's perspective is valuable to us.

Ask to get answers.